No products in the cart.
- Phone No: + 1 845 521 7198
FOLLOW US:
At the end of December 2019, a novel coronavirus, 2019-nCoV, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to the whole country of China, which has posed great threats to public health and attracted enormous attention around the world. To date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections. Intensive research on the novel emerging human infectious coronaviruses is urgently needed to elucidate their route of transmission and pathogenic mechanisms, and to identify potential drug targets, which would promote the development of effective preventive and therapeutic countermeasures. Herein, we describe the epidemic and etiological characteristics of 2019-nCoV, discuss its essential biological features, including tropism and receptor usage, summarize approaches for disease prevention and treatment, and speculate on the transmission route of 2019-nCoV.
You can fight with as by becoming a volunteer Leader.
Atque corrupti quos dolores et quas molestias excepturi sintoc piditate non provident, similique sunt inculpa qui officia deseru animi eaque ipsa quae ab illo inventore.
Atque corrupti quos dolores et quas molestias excepturi sintoc piditate non provident, similique sunt inculpa qui officia deseru animi eaque ipsa quae ab illo inventore.
Atque corrupti quos dolores et quas molestias excepturi sintoc piditate non provident, similique sunt inculpa qui officia deseru animi eaque ipsa quae ab illo inventore.
Atque corrupti quos dolores et quas molestias excepturi sintoc piditate non provident, similique sunt inculpa qui officia deseru animi eaque ipsa quae ab illo inventore.
Atque corrupti quos dolores et quas molestias excepturi sintoc piditate non provident, similique sunt inculpa qui officia deseru animi eaque ipsa quae ab illo inventore.
32 Cases Report
20 Cases Report